Literature DB >> 21416157

Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer.

Yu Tang1, Xiangtian Zeng, Fei He, Yonghui Liao, Niansong Qian, Masakazu Toi.   

Abstract

Caveolin-1 is the principal components of caveolae membranes, implicated in oncogenesis and angiogenesis. Until now, its expression and functional significance in hepatocellular carcinoma (HCC) are still unclear. In the present study, we demonstrated that expression of caveolin-1 was markedly upregulated in HCC patients. In addition, increased caveolin-1 expression correlated positively with the histological differentiation, portal venous invasion, hepatic venous invasion, intrahepatic metastases, and recurrence, suggesting a role for caveolin-1 in the progression of HCC. HepG2 cell line was transfected with pcDNA3.1/caveolin-1 to observe the significance of the change in caveolin-1 expression. We showed that caveolin-1 overexpression could not only protect HepG2 cells from apoptosis but also enhance its migration and invasion by upregulating MMP-2, MMP-9, and VEGF expressions. Collectively, our clinical and in vitro data indicate that the status of caveolin-1 expression may be one of causative factors for the invasion and poor prognosis in HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21416157     DOI: 10.1007/s12032-011-9900-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  28 in total

1.  Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.

Authors:  M Salatino; W Beguelin; M G Peters; R Carnevale; C J Proietti; M D Galigniana; C G Vedoy; R Schillaci; E H Charreau; M C Sogayar; P V Elizalde
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

2.  Increased expression of a disintegrin and metalloprotease-9 in hepatocellular carcinoma: implications for tumor progression and prognosis.

Authors:  KaiShan Tao; NianSong Qian; Yu Tang; Zhenyu Ti; WenJie Song; DaYong Cao; KeFeng Dou
Journal:  Jpn J Clin Oncol       Date:  2010-04-13       Impact factor: 3.019

3.  Current management of hepatocellular cancer.

Authors:  Bernardino Rampone; Beniamino Schiavone; Giuseppe Confuorto
Journal:  Curr Oncol Rep       Date:  2010-05       Impact factor: 5.075

4.  Bmi-1 is related to proliferation, survival and poor prognosis in pancreatic cancer.

Authors:  Wenjie Song; Kaishan Tao; Haimin Li; Chen Jin; Zhenshun Song; Jun Li; Hai Shi; Xiao Li; Zheng Dang; Kefeng Dou
Journal:  Cancer Sci       Date:  2010-03-24       Impact factor: 6.716

5.  Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.

Authors:  Kentaro Kato; Yasuhiro Hida; Masaki Miyamoto; Hideaki Hashida; Toshiya Shinohara; Tomoo Itoh; Shunichi Okushiba; Satoshi Kondo; Hiroyuki Katoh
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

6.  Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness.

Authors:  Federica Sotgia; Terence M Williams; William Schubert; Freddy Medina; Carlo Minetti; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

7.  Caveolin and thrombospondin expression during hepatocellular carcinogenesis.

Authors:  Lisa M Yerian; Robert A Anders; Maria Tretiakova; John Hart
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

Review 8.  Caveolin-1: a tumor-promoting role in human cancer.

Authors:  Maria Shatz; Mordechai Liscovitch
Journal:  Int J Radiat Biol       Date:  2008-03       Impact factor: 2.694

9.  Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma.

Authors:  M Suzuoki; M Miyamoto; K Kato; K Hiraoka; T Oshikiri; Y Nakakubo; A Fukunaga; T Shichinohe; T Shinohara; T Itoh; S Kondo; H Katoh
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

Review 10.  Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis.

Authors:  S J Schoenleber; D M Kurtz; J A Talwalkar; L R Roberts; G J Gores
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

View more
  23 in total

1.  Caveolin-1 regulates Mcl-1 stability and anoikis in lung carcinoma cells.

Authors:  Preedakorn Chunhacha; Varisa Pongrakhananon; Yon Rojanasakul; Pithi Chanvorachote
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

2.  Duplex value of caveolin-1 in non-small cell lung cancer: a meta analysis.

Authors:  Dali Chen; Cheng Shen; Heng Du; Yubin Zhou; Guowei Che
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

3.  Regulator of G-protein signaling 5 enhances portal vein invasion in hepatocellular carcinoma.

Authors:  Yumi Umeno; Sachiko Ogasawara; Jun Akiba; Satoshi Hattori; Hironori Kusano; Osamu Nakashima; Hironori Koga; Takuji Torimura; Ryoji Yamakawa; Hirohisa Yano
Journal:  Oncol Lett       Date:  2017-11-23       Impact factor: 2.967

4.  Downregulation of caveolin-1 increases the sensitivity of drug-resistant colorectal cancer HCT116 cells to 5-fluorouracil.

Authors:  Zhaoyang Li; Ning Wang; Changxin Huang; Yanhong Bao; Yiqian Jiang; Guiting Zhu
Journal:  Oncol Lett       Date:  2016-11-16       Impact factor: 2.967

5.  Prognostic value of caveolin-1 in genitourinary cancer: a meta-analysis.

Authors:  Jia-Ming Liu; Si-Hang Cheng; Xiao-Xiao Liu; Chao Xia; Wei-Wen Wang; Xue-Lei Ma
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  Downregulation of tumor growth and invasion by redox-active nanoparticles.

Authors:  Lirija Alili; Maren Sack; Claudia von Montfort; Shailendra Giri; Soumen Das; Kate S Carroll; Klaus Zanger; Sudipta Seal; Peter Brenneisen
Journal:  Antioxid Redox Signal       Date:  2013-01-24       Impact factor: 8.401

7.  Caveolin-1 is up-regulated by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma.

Authors:  Xiaohong Gai; Zhongtang Lu; Kangsheng Tu; Zheyong Liang; Xin Zheng
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

8.  Distinct dedifferentiation processes affect caveolin-1 expression in hepatocytes.

Authors:  Christoph Meyer; Johanna Dzieran; Yan Liu; Felizitas Schindler; Stefan Munker; Alexandra Müller; Cédric Coulouarn; Steven Dooley
Journal:  Cell Commun Signal       Date:  2013-01-22       Impact factor: 5.712

9.  Inherent and acquired resistance to paclitaxel in hepatocellular carcinoma: molecular events involved.

Authors:  Avtar Singh Meena; Aanchal Sharma; Ratna Kumari; Naoshad Mohammad; Shivendra Vikram Singh; Manoj Kumar Bhat
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer.

Authors:  Tao Shan; Hongwei Lu; Hong Ji; Yiming Li; Jian Guo; Xi Chen; Tao Wu
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.